- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
已发现中线买入信号。
- 长期趋势：
已有64家主力机构披露2024-12-31报告期持股数据，持仓量总计5.17亿股，占流通A股36.82%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了85%的股票
技术面评分前10的股票
近期的平均成本为6.02元。多头行情中，并且有加速上涨趋势。已发现中线买入信号。
平均成本
近期的平均成本为6.02元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.02","date":1751183901,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.06.30","stock":"0.50","trade":null,"ind":"0.83"},{"date":"2025.06.27","stock":"1.01","trade":null,"ind":"0.34"},{"date":"2025.06.26","stock":"-1.16","trade":null,"ind":"-0.48"},{"date":"2025.06.25","stock":"0.84","trade":null,"ind":"1.72"},{"date":"2025.06.24","stock":"0.50","trade":null,"ind":"1.68"},{"date":"2025.06.23","stock":"3.30","trade":null,"ind":"0.43"},{"date":"2025.06.20","stock":"0.00","trade":null,"ind":"-0.47"},{"date":"2025.06.19","stock":"-2.04","trade":null,"ind":"-1.21"},{"date":"2025.06.18","stock":"-2.16","trade":null,"ind":"0.24"},{"date":"2025.06.17","stock":"1.18","trade":null,"ind":"-0.12"},{"date":"2025.06.16","stock":"0.51","trade":null,"ind":"0.41"},{"date":"2025.06.13","stock":"-2.15","trade":null,"ind":"-1.10"},{"date":"2025.06.12","stock":"0.33","trade":null,"ind":"-0.11"},{"date":"2025.06.11","stock":"-1.31","trade":null,"ind":"0.83"},{"date":"2025.06.10","stock":"-1.29","trade":null,"ind":"-0.86"},{"date":"2025.06.09","stock":"1.81","trade":null,"ind":"0.65"},{"date":"2025.06.06","stock":"-0.65","trade":null,"ind":"-0.19"},{"date":"2025.06.05","stock":"-0.97","trade":null,"ind":"0.58"},{"date":"2025.06.04","stock":"0.00","trade":null,"ind":"0.87"},{"date":"2025.06.03","stock":"1.48","trade":null,"ind":"0.16"},{"date":"2025.05.30","stock":"0.16","trade":null,"ind":"-0.85"}]
达安基因,深证成指,医疗器械指数
压力支撑
该股压力位为6.01元，支撑位为5.97元。
[{"text":"\u538b\u529b\u4f4d","value":"6.01","date":1751212800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.97","date":1751212800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。已发现中线买入信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了35%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：06月30日 20:31
| 机构今日流向(万元) | 895.77 | 机构5日流向(万元) | -738.43 |
| 机构10日流向(万元) | -4095.79 | 机构20日流向(万元) | -9196.79 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少4942.99万股，其中基金净增仓4家，主力净减仓25家，暂未发现中长期投资价值。
截止2024-12-31，共64家主力机构（基金59家，一般法人5家），持仓量总计51672.56万股，占流通A股36.82%
其中，基金持仓与2024-06-30相比：
增仓：17家 ，增持 93.16万股
减仓：13家 ，减持 58.96万股
新出现在主力名单中：26家 ，持有184.6万股
从主力名单中消失：51家 ，原持有4594.64万股
其中，基金持仓与2024-06-30相比：
增仓：17家 ，增持 93.16万股
减仓：13家 ，减持 58.96万股
新出现在主力名单中：26家 ，持有184.6万股
从主力名单中消失：51家 ，原持有4594.64万股
消息面诊股
诊断结果：5.5消息面打败了10%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 达安基因：6月27日获融资买入727.29万元，占
2025-06-30 - 达安基因：6月26日获融资买入592.20万元
2025-06-27 - 达安基因：6月25日获融资买入1505.12万元，
2025-06-26 - 达安基因：6月24日获融资买入452.77万元，占
2025-06-25 - 达安基因：截至2025年5月30日公司股东总户数约
2025-06-24 - 达安基因：6月23日获融资买入538.66万元，占
2025-06-24 - 达安基因：6月20日获融资买入299.51万元，占
2025-06-23 - 达安基因：公司生免平台已有相关肿瘤标志物检测产品，
2025-06-20 - 达安基因：公司新设战略规划部是落实生态产业链战略的
2025-06-20 - 达安基因：6月19日获融资买入419.75万元
2025-06-20
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-05-10 |
| 一般消息 | 高管变动 | 工作原因 | 2025-04-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-19 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-03-29 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-25 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：3.5行业面打败了35%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.06.30","price":"0.83","value":null},{"date":"2025.06.27","price":"0.34","value":null},{"date":"2025.06.26","price":"-0.48","value":null},{"date":"2025.06.25","price":"1.72","value":null},{"date":"2025.06.24","price":"1.68","value":null},{"date":"2025.06.23","price":"0.43","value":null},{"date":"2025.06.20","price":"-0.47","value":null},{"date":"2025.06.19","price":"-1.21","value":null},{"date":"2025.06.18","price":"0.24","value":null},{"date":"2025.06.17","price":"-0.12","value":null},{"date":"2025.06.16","price":"0.41","value":null},{"date":"2025.06.13","price":"-1.10","value":null},{"date":"2025.06.12","price":"-0.11","value":null},{"date":"2025.06.11","price":"0.83","value":null},{"date":"2025.06.10","price":"-0.86","value":null},{"date":"2025.06.09","price":"0.65","value":null},{"date":"2025.06.06","price":"-0.19","value":null},{"date":"2025.06.05","price":"0.58","value":null},{"date":"2025.06.04","price":"0.87","value":null},{"date":"2025.06.03","price":"0.16","value":null},{"date":"2025.05.30","price":"-0.85","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华强科技 | 67.40% | 38.73% | 4.9分 |
| 2 | 浩欧博 | 41.71% | 10.95% | 5.2分 |
| 3 | 爱朋医疗 | 29.84% | 13.49% | 5.8分 |
| 4 | 乐普医疗 | 21.20% | 5.59% | 5.5分 |
| 5 | 天臣医疗 | 20.04% | 7.11% | 5.5分 |
| 6 | 翔宇医疗 | 16.83% | 21.87% | 5.5分 |
| 8 | 东富龙 | 12.63% | 2.78% | 5.7分 |
| 10 | 南卫股份 | 11.15% | 2.36% | 4.4分 |
| 12 | 春立医疗 | 10.65% | 15.18% | 5.1分 |
| 14 | 东方生物 | 8.75% | 4.15% | 4.3分 |
| 16 | 仁度生物 | 8.10% | 5.50% | 4.8分 |
| 18 | 睿昂基因 | 7.43% | 6.57% | 5.0分 |
| 20 | 三诺生物 | 6.91% | 6.31% | 6.3分 |
| 22 | 奥泰生物 | 6.58% | 4.93% | 5.1分 |
| 24 | 康为世纪 | 6.33% | -1.47% | 4.2分 |
| 26 | 爱迪特 | 6.12% | 9.98% | 6.5分 |
| 28 | 赛科希德 | 5.84% | 4.87% | 4.8分 |
| 30 | 天益医疗 | 5.68% | 3.12% | 5.6分 |
| 32 | 维力医疗 | 5.39% | 3.92% | 5.2分 |
| 34 | 透景生命 | 4.99% | 4.55% | 5.7分 |
| 36 | 东方海洋 | 4.81% | 9.27% | 5.4分 |
| 38 | 艾德生物 | 4.67% | 2.13% | 5.8分 |
| 40 | 振德医疗 | 4.61% | 1.39% | 5.3分 |
| 42 | 五洲医疗 | 4.47% | 3.24% | 5.1分 |
| 44 | 康德莱 | 4.34% | 5.19% | 5.1分 |
| 46 | 楚天科技 | 4.14% | 4.00% | 5.5分 |
| 48 | 中红医疗 | 4.09% | 4.45% | 5.9分 |
| 50 | 科美诊断 | 3.95% | 3.52% | 4.6分 |
| 52 | 爱威科技 | 3.91% | 4.47% | 5.1分 |
| 54 | 理邦仪器 | 3.80% | 4.25% | 6.1分 |
| 56 | 正川股份 | 3.70% | 3.64% | 4.7分 |
| 58 | 凯普生物 | 3.57% | 3.57% | 5.5分 |
| 60 | 黄山胶囊 | 3.07% | 4.68% | 6.0分 |
| 62 | 之江生物 | 2.97% | 2.85% | 4.3分 |
| 64 | 科华生物 | 2.68% | 3.02% | 5.1分 |
| 66 | 迪瑞医疗 | 2.51% | 1.98% | 5.5分 |
| 68 | 安必平 | 2.39% | 9.28% | 4.2分 |
| 70 | 伟思医疗 | 2.20% | 7.64% | 5.1分 |
| 72 | 南微医学 | 1.85% | 5.38% | 5.5分 |
| 74 | 赛诺医疗 | 1.54% | 4.47% | 4.6分 |
| 76 | 安杰思 | 1.17% | 3.96% | 4.8分 |
| 78 | 尚荣医疗 | 1.08% | 2.45% | 5.5分 |
| 80 | 奥精医疗 | 1.00% | 3.91% | 3.6分 |
| 82 | 可孚医疗 | 0.85% | 2.60% | 5.7分 |
| 84 | 欧普康视 | 0.66% | 3.32% | 5.4分 |
| 86 | 祥生医疗 | 0.54% | 5.93% | 5.0分 |
| 88 | 英科医疗 | 0.30% | 0.68% | 5.4分 |
| 90 | 康拓医疗 | 0.13% | 6.30% | 5.7分 |
| 92 | 麦克奥迪 | -0.19% | 5.82% | 5.7分 |
| 94 | 济高发展 | -0.33% | 3.73% | 4.0分 |
| 96 | 奥美医疗 | -0.35% | 1.30% | 5.5分 |
| 98 | 迈瑞医疗 | -0.50% | -0.48% | 4.7分 |
| 100 | 昊海生科 | -0.60% | 4.59% | 4.8分 |
| 102 | 健帆生物 | -1.19% | 2.96% | 5.5分 |
| 104 | 三鑫医疗 | -1.71% | 2.03% | 5.0分 |
| 106 | 新华医疗 | -2.57% | 1.41% | 4.3分 |
| 108 | 微电生理 | -2.91% | 2.13% | 4.6分 |
| 110 | 大博医疗 | -3.46% | 1.94% | 5.5分 |
| 112 | 三友医疗 | -3.71% | 3.44% | 4.7分 |
| 114 | 英诺特 | -3.98% | 2.66% | 4.4分 |
| 116 | 新产业 | -5.45% | -0.51% | 5.1分 |
| 118 | 奕瑞科技 | -5.86% | 0.02% | 4.3分 |
| 120 | 佰仁医疗 | -6.37% | -0.50% | 5.1分 |
| 122 | 联影医疗 | -7.05% | -0.28% | 4.7分 |
| 124 | 福瑞股份 | -8.21% | 5.36% | 4.9分 |
| 126 | 迈普医学 | -9.47% | 8.43% | 6.5分 |
| 128 | 万泰生物 | -11.98% | -2.87% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 83/251 ， 105/251。
[{"date":"2025-03-31","value":"0.67","vol":"1.15"},{"date":"2024-12-31","value":"-11.04","vol":"0.53"},{"date":"2024-09-30","value":"-5.84","vol":"4.75"},{"date":"2024-06-30","value":"-4.61","vol":"3.53"},{"date":"2024-03-31","value":"-4.18","vol":"1.63"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.67 | -11.04 | -5.84 | -4.61 | -4.18 |
| 行业(%) | 1.15 | 0.53 | 4.75 | 3.53 | 1.63 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"31.04","vol":"51.81"},{"date":"2024-12-31","value":"37.55","vol":"52.63"},{"date":"2024-09-30","value":"39.98","vol":"53.58"},{"date":"2024-06-30","value":"41.22","vol":"53.70"},{"date":"2024-03-31","value":"55.84","vol":"53.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
31.04 | 37.55 | 39.98 | 41.22 | 55.84 |
| 行业(%) | 51.81 | 52.63 | 53.58 | 53.70 | 53.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 96/251 ， 13/251。
[{"date":"2025-03-31","value":"-14.71","vol":"-0.92"},{"date":"2024-12-31","value":"-27.76","vol":"0.64"},{"date":"2024-09-30","value":"-29.83","vol":"0.79"},{"date":"2024-06-30","value":"-25.33","vol":"0.16"},{"date":"2024-03-31","value":"-41.85","vol":"-1.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.71 | -27.76 | -29.83 | -25.33 | -41.85 |
| 行业(%) | -0.92 | 0.64 | 0.79 | 0.16 | -1.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"114.57","vol":"-4.25"},{"date":"2024-12-31","value":"-983.98","vol":"-24.11"},{"date":"2024-09-30","value":"-242.58","vol":"-20.40"},{"date":"2024-06-30","value":"-199.12","vol":"8.56"},{"date":"2024-03-31","value":"-1093.65","vol":"-16.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
114.57 | -983.98 | -242.58 | -199.12 | -1093.65 |
| 行业(%) | -4.25 | -24.11 | -20.40 | 8.56 | -16.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 122/251 ， 50/251。
[{"date":"2025-03-31","value":"0.02","vol":"0.08"},{"date":"2024-12-31","value":"0.08","vol":"0.35"},{"date":"2024-09-30","value":"0.06","vol":"0.26"},{"date":"2024-06-30","value":"0.04","vol":"0.18"},{"date":"2024-03-31","value":"0.02","vol":"0.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.02 | 0.08 | 0.06 | 0.04 | 0.02 |
| 行业(次) | 0.08 | 0.35 | 0.26 | 0.18 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.58","vol":"0.55"},{"date":"2024-12-31","value":"2.43","vol":"2.33"},{"date":"2024-09-30","value":"1.48","vol":"1.67"},{"date":"2024-06-30","value":"0.95","vol":"1.13"},{"date":"2024-03-31","value":"0.36","vol":"0.54"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 2.43 | 1.48 | 0.95 | 0.36 |
| 行业(次) | 0.55 | 2.33 | 1.67 | 1.13 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-21.69","vol":"4.01"},{"date":"2024-12-31","value":"64.10","vol":"29.58"},{"date":"2024-09-30","value":"58.99","vol":"15.37"},{"date":"2024-06-30","value":"54.31","vol":"13.04"},{"date":"2024-03-31","value":"-45.28","vol":"2.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -21.69 | 64.10 | 58.99 | 54.31 | -45.28 |
| 行业 | 4.01 | 29.58 | 15.37 | 13.04 | 2.55 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.48","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.43","vol":"2.31"},{"date":"2024-03-31","value":"","vol":"0.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.48 | - | 0.43 | - |
| 行业 | 0.00 | 2.19 | 0.01 | 2.31 | 0.06 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/251 ， 34/251。
[{"date":"2025-03-31","value":"2.91","vol":"5.89"},{"date":"2024-12-31","value":"2.92","vol":"5.34"},{"date":"2024-09-30","value":"4.10","vol":"5.97"},{"date":"2024-06-30","value":"4.15","vol":"5.95"},{"date":"2024-03-31","value":"3.74","vol":"6.44"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.91 | 2.92 | 4.10 | 4.15 | 3.74 |
| 行业 | 5.89 | 5.34 | 5.97 | 5.95 | 6.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.03","vol":"4.77"},{"date":"2024-12-31","value":"1.88","vol":"4.32"},{"date":"2024-09-30","value":"2.19","vol":"4.82"},{"date":"2024-06-30","value":"2.32","vol":"4.90"},{"date":"2024-03-31","value":"2.07","vol":"5.37"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.03 | 1.88 | 2.19 | 2.32 | 2.07 |
| 行业 | 4.77 | 4.32 | 4.82 | 4.90 | 5.37 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 80/251 ， 79/251。
[{"date":"2025-03-31","value":"13.63","vol":"21.24"},{"date":"2024-12-31","value":"14.97","vol":"21.92"},{"date":"2024-09-30","value":"13.84","vol":"21.09"},{"date":"2024-06-30","value":"13.89","vol":"21.07"},{"date":"2024-03-31","value":"15.21","vol":"20.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
13.63 | 14.97 | 13.84 | 13.89 | 15.21 |
| 行业(%) | 21.24 | 21.92 | 21.09 | 21.07 | 20.36 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.16","vol":"0.57"},{"date":"2024-12-31","value":"0.18","vol":"0.55"},{"date":"2024-09-30","value":"0.17","vol":"0.38"},{"date":"2024-06-30","value":"0.17","vol":"0.37"},{"date":"2024-03-31","value":"0.19","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.16 | 0.18 | 0.17 | 0.17 | 0.19 |
| 行业(%) | 0.57 | 0.55 | 0.38 | 0.37 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"36.18","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"54.12","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.05","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]